FRM
RGNX icon

Fox Run Management’s Regenxbio RGNX Stock Holding History

Fox Run Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17,501
Closed -$252K – 1188
2025
Q4 		$252K Buy
+17,501
New +$218K 0.04% 742
2025
Q1 		– Sell
-13,784
Closed -$107K – 1172
2024
Q4 		$107K Sell
13,784
-656
-5% -$6.16K 0.02% 802
2024
Q3 		$151K Buy
+14,440
New +$176K 0.03% 702
2019
Q3 		– Sell
-5,240
Closed -$269K – 528
2019
Q2 		$269K Buy
+5,240
New +$262K 0.18% 269
2019
Q1 		– Sell
-10,975
Closed -$460K – 653
2018
Q4 		$460K Buy
+10,975
New +$644K 0.24% 133

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return